Cargando…

Identification of HIV-1 Epitopes that Induce the Synthesis of a R5 HIV-1 Suppression Factor by Human CD4(+) T Cells Isolated from HIV-1 Immunized Hu-PBL SCID Mice

We have previously reported that immunization of the severe combined immunodeficiency (SCID) mice reconstituted with human peripheral blood mononuclear cells (PBMC) (hu-PBL-SCID mice) with inactivated human immunodeficiency virus type-1 (HIV-1)-pulsed-autologous dendritic cells (HIV-DC) elicits HIV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Atsushi, Tanaka, Reiko, Kodama, Akira, Yamamoto, Naoki, Ansari, Aftab A., Tanaka, Yuetsu
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270741/ https://www.ncbi.nlm.nih.gov/pubmed/16584108 http://dx.doi.org/10.1080/17402520500391557

Ejemplares similares

A novel and simple method for generation of human dendritic cells from unfractionated peripheral blood mononuclear cells within 2 days: its application for induction of HIV-1-reactive CD4(+) T cells in the hu-PBL SCID mice
por: Kodama, Akira, et al.
Publicado: (2013)

Complete prevention of HTLV-1 infection in humanized mice (hu-PBL SCID) by a neutralizing monoclonal antibody to envelope gp46
por: Saito, Mineki, et al.
Publicado: (2014)

Critical Contribution of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) to Apoptosis of Human Cd4(+)T Cells in HIV-1–Infected Hu-Pbl-Nod-Scid Mice
por: Miura, Yoshiharu, et al.
Publicado: (2001)

The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
por: Okada, Masaji, et al.
Publicado: (2005)

The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection
por: Steyaert, Sophia, et al.
Publicado: (2007)

Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
por: Okada, Masaji, et al.
Publicado: (2007)

Development of Vaccines and Passive Immunotherapy Against Sars Coronavirus Using Mouse and Scid-PBL/hu Mouse Models
por: Okada, Masaji, et al.
Publicado: (2006)

Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras
Publicado: (1994)

Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID- hu mice after peripheral inoculation with HIV-1
Publicado: (1994)

The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice
por: Saito, Mineki, et al.
Publicado: (2014)

Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice
por: Stoddart, Cheryl A., et al.
Publicado: (2007)

Potent Immune Response against HIV-1 and Protection from Virus Challenge in hu-PBL-SCID Mice Immunized with Inactivated Virus-pulsed Dendritic Cells Generated in the Presence of IFN-α
por: Lapenta, Caterina, et al.
Publicado: (2003)

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses
por: Adachi, Tetsuya, et al.
Publicado: (2011)

Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras
por: Tang, Yunlian, et al.
Publicado: (2011)

Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model
por: Zhou, Zhi-Feng, et al.
Publicado: (2019)

Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice
por: Santini, Stefano M., et al.
Publicado: (2000)

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice
por: Bhargavan, Biju, et al.
Publicado: (2021)

Natural OX40L expressed on human T cell leukemia virus type-I-immortalized T cell lines interferes with infection of activated peripheral blood mononuclear cells by CCR5-utilizing human immunodeficiency virus
por: Kasahara, Daigo, et al.
Publicado: (2013)

Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection
por: Tanaka, Yuetsu, et al.
Publicado: (2014)

Evaluation of hGM-CSF/hTNFα surface-modified prostate cancer therapeutic vaccine in the huPBL-SCID chimeric mouse model
por: Lai, Shouhua, et al.
Publicado: (2015)

Conservation of a Neutralization Epitope of Human T-cell Leukemia Virus Type 1 (HTLV-1) among Currently Endemic Clinical Isolates in Okinawa, Japan
por: Mizuguchi, Mariko, et al.
Publicado: (2020)

beta-estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBL
por: Zhang, Mingjie, et al.
Publicado: (2008)

Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1–HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1
por: Tang, Yuyang, et al.
Publicado: (2018)

P1244: ROLE OF SELECT T HELPER CELL MONONUCLEAR CELL SUBSETS PROMOTING EPSTEIN-BARR VIRUS-DRIVEN LYMPHOPROLIFERATIVE DISEASE IN THE HU-PBL-SCID MODEL
por: Ahmed, E. H., et al.
Publicado: (2022)

Generation of direct antigen-sandwich enzyme-linked immune-sorbent assays (ELISA) for quantitation of HTLV-1 gp46, p24, Tax and related host cellular antigens OX40, OX40L and CD25
por: Tanaka, Reiko, et al.
Publicado: (2014)

Successful development of novel monoclonal antibodies against HTLV-1 bZIP factor and their applications in studying the pathogenesis of HAM/TSP
por: Saito, Mineki, et al.
Publicado: (2011)

P03-02. SCID-hu mice generate HIV specific human immune responses after gp96 vaccination
por: Gonzalez, LE, et al.
Publicado: (2009)

Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses
por: Brunetti, Jesús Emanuel, et al.
Publicado: (2023)

Conserved HIV Epitopes for an Effective HIV Vaccine
por: Sahay, Bikash, et al.
Publicado: (2017)

Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor: EQUIPOTENT TO C34 AND T-20 IN VITRO WITH SUSTAINED ACTIVITY IN SCID-HU THY/LIV MICE
por: Stoddart, Cheryl A., et al.
Publicado: (2008)

Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model
por: Stoddart, Cheryl A., et al.
Publicado: (2022)

Switching and emergence of CTL epitopes in HIV-1 infection
por: Han, Chungyong, et al.
Publicado: (2014)

An Overview of Human Anti-HIV-1 Neutralizing Antibodies against Diverse Epitopes of HIV-1
por: Kumar, Sanjeev, et al.
Publicado: (2023)

Long-term human hematopoiesis in the SCID-hu mouse
Publicado: (1990)

HIV-1 protective epitope-specific CD8(+) T cells in HIV-1-exposed seronegative individuals
por: Chikata, Takayuki, et al.
Publicado: (2023)

Identifying epitopes of HIV-1 that induce protective antibodies
por: Zolla-Pazner, Susan
Publicado: (2004)

Immunodominant HIV-1 Cd4+ T Cell Epitopes in Chronic Untreated Clade C HIV-1 Infection
por: Ramduth, Danni, et al.
Publicado: (2009)

T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
por: Zhang, Zhiqing, et al.
Publicado: (2018)

The Effect of HLA Polymorphisms on the Recognition of Gag Epitopes in HIV-1 CRF01_AE Infection
por: Sriwanthana, Busarawan, et al.
Publicado: (2012)

HIV-1 Suppressive Sequences Are Modulated by Rev Transport of Unspliced RNA and Are Required for Efficient HIV-1 Production
por: Noguchi, Kousei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a6mjemfu4icokrelo2crhsaodp